Fulgent Genetics Inc (FLGT)
NASDAQ:FLGT
Holding FLGT?
Track your performance easily

Fulgent Genetics (FLGT) Financial Statements

1,619 Followers

Fulgent Genetics Financial Overview

Fulgent Genetics's market cap is currently ―. The company's EPS TTM is $-5.482; its P/E ratio is -3.94; Fulgent Genetics is scheduled to report earnings on November 8, 2024, and the estimated EPS forecast is $-0.15. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 71.03M$ 64.48M$ 70.50M$ 84.69M$ 67.85M
Gross Profit$ 26.49M$ 22.10M$ 25.23M$ 39.84M$ 20.57M
EBIT$ -11.21M$ -14.17M$ -30.89M$ 6.86M$ -14.56M
EBITDA$ -5.06M$ -7.51M$ -24.35M$ 13.28M$ -8.25M
Net Income Common Stockholders$ -8.74M$ -13.46M$ -128.15M$ -13.08M$ -11.23M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 65.11M$ 54.68M$ 97.47M$ 84.08M$ 58.35M
Total Assets$ 1.23B$ 1.23B$ 1.24B$ 1.36B$ 1.35B
Total Debt$ 412.00K$ 413.00K$ 1.18M$ 2.89M$ 4.56M
Net Debt$ -64.70M$ -54.26M$ -96.29M$ -81.19M$ -53.79M
Total Liabilities$ 117.50M$ 103.24M$ 102.04M$ 96.56M$ 91.25M
Stockholders Equity$ 1.13B$ 1.13B$ 1.14B$ 1.26B$ 1.26B
Cash Flow-
Free Cash Flow$ -8.64M$ 3.47M$ 12.16M$ 5.34M$ -2.20M
Operating Cash Flow$ 4.29M$ 7.27M$ 14.93M$ 10.24M$ 9.72M
Investing Cash Flow$ 7.30M$ -47.19M$ 24.27M$ 20.08M$ -1.10M
Financing Cash Flow$ -1.15M$ -2.81M$ -25.95M$ -4.47M$ -16.26M
Currency in USD

Fulgent Genetics Earnings and Revenue History

Fulgent Genetics Debt to Assets

Fulgent Genetics Cash Flow

Fulgent Genetics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis